This compound is primarily explored in pharmaceutical research due to its structural similarity to benzazepine derivatives, which are known for their potential therapeutic effects. It is studied for its possible applications in neurological disorders, particularly as a modulator of dopamine receptors. Its methoxy group enhances its ability to cross the blood-brain barrier, making it a candidate for treating conditions like Parkinson's disease or schizophrenia. Additionally, its unique structure may contribute to developing novel antidepressants or anxiolytics, as benzazepine analogs have shown promise in regulating mood and anxiety. Research is ongoing to determine its efficacy and safety in these applications.